Skip to content
value.today

Primary Bioscience, Inc.

🇺🇸 Seattle, Washington, USATechnologyFounded 2023
Total raised
$1 M
1 round on record
Latest round
$1 M
Oct 2025
First round on record
Oct 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Primary Bioscience, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2025$1 MNo. 1Under $2 million

Primary Bioscience, Inc.: Raise no. 1, Oct 2025

Investors in this round

3 investors had bought by the notice of Jun 23, 2026: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Stacy Anderson · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stacy Anderson, Chief Executive Officer. Newest notice filed Jun 23, 2026 (1 amendment). Read the notice at the SEC.

equity, optionsSEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Primary Bioscience, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jun 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Primary Bioscience, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Primary Bioscience, Inc.
NameRoleNamed in
Stacy AndersonExecutive officerJun 2026
Stacy AndersonDirectorJun 2026
Stacy AndersonPromoterJun 2026